Dose based on m² [General Sta­tis­tics]

posted by VK – Russia, 2013-07-17 12:35 (4376 d 11:43 ago) – Posting: # 10991
Views: 10,993

Dear HS and colleagues,

I am a newcomer, I work in BE bioanalytics lab in BRIC country (right btw Brazil and India). We recently had a BE project (single dose, two-way crossover) with a cytostatic which is prescribed based on body surface area. Thus c.a. 70% of the sample size received Х mg of either R/T in each period, while 30% received 0.75Х mg or 1.25Х mg.
We did regular calculations however authorities require different approach. They want us to use only X mg data for statistical evaluation, saying that we cannot use 30% because of the different dose.
I am currently trying to think of argumentation persuading authorities to accept calculations based on the whole data set. Unfortunately I cannot refer to common sense and basic statistical considerations that is why I need more like a reference to a GL or an article. I would greatly appreciate if you could help me with few references if any.
Sincerely,

VK

Complete thread:

UA Flag
Activity
 Admin contact
23,430 posts in 4,931 threads, 1,673 registered users;
38 visitors (0 registered, 38 guests [including 8 identified bots]).
Forum time: 00:19 CEST (Europe/Vienna)

To know that we know what we know,
and to know that we do not know what we do not know,
that is true knowledge.    Nicolaus Copernicus

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5